NDC 69097-381

lenalidomide

Lenalidomide

lenalidomide is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Cipla Usa Inc.. The primary component is Lenalidomide.

Product ID69097-381_8f58ba29-15c3-4f20-9d60-2b688061dba1
NDC69097-381
Product TypeHuman Prescription Drug
Proprietary Namelenalidomide
Generic NameLenalidomide
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2022-09-06
Marketing CategoryANDA /
Application NumberANDA210435
Labeler NameCipla USA Inc.
Substance NameLENALIDOMIDE
Active Ingredient Strength5 mg/1
Pharm ClassesThalidomide Analog [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 69097-381-73

28 CAPSULE in 1 BOTTLE, PLASTIC (69097-381-73)
Marketing Start Date2022-09-06
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "lenalidomide" or generic name "Lenalidomide"

NDCBrand NameGeneric Name
0378-1936LenalidomideLenalidomide
0378-1937LenalidomideLenalidomide
0378-1940LenalidomideLenalidomide
0378-1941LenalidomideLenalidomide
0480-1242LenalidomideLenalidomide
0480-1243LenalidomideLenalidomide
0480-1244LenalidomideLenalidomide
0480-1246LenalidomideLenalidomide
43598-511LenalidomideLenalidomide
43598-512LenalidomideLenalidomide
43598-513LenalidomideLenalidomide
43598-514LenalidomideLenalidomide
43598-515LenalidomideLenalidomide
43598-516LenalidomideLenalidomide
47781-484LENALIDOMIDELenalidomide
47781-485LENALIDOMIDELenalidomide
47781-486LENALIDOMIDELenalidomide
47781-488LENALIDOMIDELenalidomide
59572-402RevlimidLenalidomide
59572-405RevlimidLenalidomide

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.